(Q38100382)

23601960

28 August 2017

title

Treatment of status epilepticus with ketamine, are we there yet? (English)

1 reference

28 August 2017

1 reference

Frederic Dorandeu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

Franck Dhote

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

Laure Barbier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

Benjamin Baccus

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

Guy Testylier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

language of work or name

1 reference

20 April 2013

1 reference

23601960

CNS Neuroscience & Therapeutics

28 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

page(s)

411-427

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

Mechanisms of status epilepticus: an evidence-based review

14 May 2020

cites work

1 reference

Recent and future advances in the treatment of status epilepticus

21 January 2018

1 reference

Status epilepticus: a critical review

21 January 2018

1 reference

Status epilepticus: pathophysiology and management in adults

21 January 2018

1 reference

New targets for pharmacological intervention in the glutamatergic synapse

21 January 2018

1 reference

Ionotropic and metabotropic glutamate receptor structure and pharmacology

21 January 2018

1 reference

The NMDA receptor complex: a promising target for novel antiepileptic strategies

21 January 2018

1 reference

The pharmacological manipulation of glutamate receptors and neuroprotection

21 January 2018

1 reference

Soman-induced seizures: limbic activity, oxidative stress and neuroprotective proteins

21 January 2018

1 reference

Prolonged inflammatory gene response following soman-induced seizures in mice

21 January 2018

1 reference

Central neuro-inflammatory gene response following soman exposure in the rat.

21 January 2018

1 reference

Soman-induced interleukin-1 beta mRNA and protein in rat brain

21 January 2018

1 reference

Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats

21 January 2018

1 reference

Neuropharmacology of phencyclidine: basic mechanisms and therapeutic potential

21 January 2018

1 reference

Ketamine, phencyclidine, and MK-801 protect against kainic acid-induced seizure-related brain damage.

21 January 2018

1 reference

Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam

21 January 2018

1 reference

Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman

21 January 2018

1 reference

Anticonvulsant effects of diazepam and MK-801 in soman poisoning.

21 January 2018

1 reference

Anticonvulsants for poisoning by the organophosphorus compound soman: Pharmacological mechanisms

21 January 2018

1 reference

Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology

21 January 2018

1 reference

Pharmacological modulation of soman-induced seizures.

21 January 2018

1 reference

Effects of thienylphencyclidine (TCP) on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neurotoxicity

21 January 2018

1 reference

Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour

21 January 2018

1 reference

The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

21 January 2018

1 reference

Effects of TCP on spatial memory: comparison with MK-801.

21 January 2018

1 reference

Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11.

21 January 2018

1 reference

Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support

21 January 2018

1 reference

Neuroprotection from soman-induced seizures in the rodent: evaluation with diffusion- and T2-weighted magnetic resonance imaging.

21 January 2018

1 reference

21 January 2018

1 reference

Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).

21 January 2018

1 reference

Ketamine in the field: the use of ketamine for induction of anaesthesia before intubation in injured patients in the field

21 January 2018

1 reference

Ketamine: new indications for an old drug

21 January 2018

1 reference

Ketamine: use in anesthesia

21 January 2018

1 reference

Anaesthesia in the field. Spontaneous ventilation--a new technique.

21 January 2018

1 reference

Total intravenous anaesthesia for military surgery. A technique using ketamine, midazolam and vecuronium

21 January 2018

1 reference

Ketamine may be the first choice for anesthesia in burn patients

21 January 2018

1 reference

Ketamine for prehospital use: new look at an old drug

21 January 2018

1 reference

Chronic administration of ketamine for analgesia

21 January 2018

1 reference

Ketamine in pain management.

21 January 2018

1 reference

Ketamine as a fast acting antidepressant: current knowledge and open questions.

21 January 2018

1 reference

Patterns of use and harms associated with non-medical ketamine use.

21 January 2018

1 reference

From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine

21 January 2018

1 reference

Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs

21 January 2018

1 reference

21 January 2018

Anaesthesia and epilepsy

1 reference

21 January 2018

1 reference

Neurology and neuropathology of Soman-induced brain injury: an overview

21 January 2018

1 reference

Soman-induced convulsions in rats terminated with pharmacological agents after 45 min: neuropathology and cognitive performance

21 January 2018

1 reference

Long-term behavioral consequences of soman poisoning in mice

21 January 2018

1 reference

Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus

21 January 2018

1 reference

Spontaneous recurrent seizures after status epilepticus induced by soman in Sprague-Dawley rats

21 January 2018

1 reference

Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy

21 January 2018

1 reference

Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties

21 January 2018

1 reference

Neurochemical mechanisms in soman-induced seizures

21 January 2018

1 reference

Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction

21 January 2018

1 reference

Treatment of refractory status epilepticus: literature review and a proposed protocol

21 January 2018

1 reference

Intravenous Lacosamide in refractory nonconvulsive status epilepticus

21 January 2018

1 reference

Combination anticonvulsant treatment of soman-induced seizures

21 January 2018

1 reference

Pharmacological agents, hippocampal EEG, and anticonvulsant effects on soman-induced seizures in rats

21 January 2018

1 reference

Efficacy of immediate and subsequent therapies against soman-induced seizures and lethality in rats

21 January 2018

1 reference

Enhanced efficacy of anticonvulsants when combined with levetiracetam in soman-exposed rats

21 January 2018

1 reference

Refractory generalised convulsive status epilepticus : a guide to treatment

21 January 2018

1 reference

New management strategies in the treatment of status epilepticus

21 January 2018

1 reference

Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig.

21 January 2018

1 reference

Comparison of the intramuscular, intranasal or sublingual routes of midazolam administration for the control of soman-induced seizures

21 January 2018

1 reference

Efficacy of the bone injection gun in the treatment of organophosphate poisoning

21 January 2018

1 reference

Effects of fosphenytoin on nerve agent-induced status epilepticus

21 January 2018

1 reference

The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy

21 January 2018

1 reference

The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol

21 January 2018

1 reference

Ketamine controls prolonged status epilepticus

21 January 2018

1 reference

N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.

21 January 2018

1 reference

NMDA receptor antagonists and limbic status epilepticus: a comparison with standard anticonvulsants

21 January 2018

1 reference

Developmental changes of ketamine action against epileptic afterdischarges induced by hippocampal stimulation in rats.

21 January 2018

1 reference

Long-lasting increased excitability differs in dentate gyrus vs. CA1 in freely moving chronic epileptic rats after electrically induced status epilepticus

21 January 2018

1 reference

Effects of etomidate, ketamine or propofol, and their combinations with conventional antiepileptic drugs on amygdala-kindled convulsions in rats

21 January 2018

1 reference

Interactions between non-barbiturate injectable anesthetics and conventional antiepileptic drugs in the maximal electroshock test in mice--an isobolographic analysis

21 January 2018

1 reference

Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.

21 January 2018

1 reference

Action of ketamine of paroxysmal discharges provoked by air emboli in the baboon Papio papio

21 January 2018

1 reference

The crude extract from the sea anemone, Bunodosoma caissarum elicits convulsions in mice: possible involvement of the glutamatergic system

21 January 2018

1 reference

Ventricular enlargement and the lithium/pilocarpine seizure model: possible explanation for agonistic behaviour

21 January 2018

1 reference

Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine

21 January 2018

1 reference

Medical management of organophosphate-induced seizures

21 January 2018

1 reference

Ketamine reduces neuronal degeneration and anxiety levels when administered during early life-induced status epilepticus in rats

21 January 2018

1 reference

Ketamine Prevents Learning Impairment When Administered Immediately after Status Epilepticus Onset

21 January 2018

1 reference

Normal spatial memory following postseizure treatment with ketamine: selective damage attenuates memory deficits in brain-damaged rodents

21 January 2018

1 reference

Normal spatial and contextual learning for ketamine-treated rats in the pilocarpine epilepsy model

21 January 2018

1 reference

The neuromatrix and the epileptic brain: behavioral and learning preservation in limbic epileptic rats treated with ketamine but not acepromazine

21 January 2018

1 reference

The control of kainic acid-induced status epilepticus

21 January 2018

1 reference

Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus.

21 January 2018

1 reference

Neuroprotective effect of ketamine administered after status epilepticus onset.

21 January 2018

1 reference

Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures

21 January 2018

1 reference

Extreme obesity in female rats following prepuberal induction of lithium-pilocarpine seizures and a single injection of acepromazine

21 January 2018

1 reference

Insidious weight gain in prepubertal seized rats treated with an atypical neuroleptic: the role of food consumption, fluid consumption, and spontaneous ambulatory activity

21 January 2018

1 reference

Large differences in blood measures, tissue weights, and focal areas of damage 1 year after postseizure treatment with acepromazine or ketamine

21 January 2018

1 reference

A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation

21 January 2018

1 reference

Study pharmacologic of the GABAergic and glutamatergic drugs on seizures and status epilepticus induced by pilocarpine in adult Wistar rats

21 January 2018

1 reference

Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus

21 January 2018

1 reference

Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs

21 January 2018

1 reference

Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice

21 January 2018

1 reference

Prediction of neuroprotective treatment efficiency using a HRMAS NMR-based statistical model of refractory status epilepticus on mouse: a metabolomic approach supported by histology

21 January 2018

1 reference

NMDA-induced seizures in developing rats cause long-term learning impairment and increased seizure susceptibility

21 January 2018

1 reference

A comparison of PCP-like compounds for NMDA antagonism in two in vivo models

21 January 2018

1 reference

Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice

21 January 2018

1 reference

Influence of ketamine on the neuronal death caused by NMDA in the rat hippocampus.

21 January 2018

1 reference

Ketamine and MK-801 prevent degeneration of thalamic neurons induced by focal cortical seizures.

21 January 2018

1 reference

Lack of correlation between the anaesthetic and anti-convulsant potencies of althesin, ketamine and methohexitone.

21 January 2018

1 reference

Ketamine suppresses both bicuculline- and picrotoxin-induced generalized tonic-clonic seizures during ontogenesis

21 January 2018

1 reference

Effects of ketamine on EEG activity in cats and monkeys

21 January 2018

1 reference

An investigation on the mechanism of anticonvulsant action of ketamine and phencyclidine on convulsions due to cortical application of penicillin in rabbits.

21 January 2018

1 reference

Ketamine: convulsant or anti-convulsant?

21 January 2018

1 reference

Voltage-dependent calcium channel and NMDA receptor antagonists augment anticonvulsant effects of lithium chloride on pentylenetetrazole-induced clonic seizures in mice

21 January 2018

1 reference

Effects of ketamine on metrazol-induced seizures during ontogenesis in rats

21 January 2018

1 reference

The anticonvulsant activity of ketamine agains siezures induced by pentylenetetrazol and mercaptopropionic acid

21 January 2018

1 reference

Effect of anesthetics on neuropathologic sequelae of status epilepticus in rats

21 January 2018

1 reference

Ketamine reduces lidocaine-induced seizures in mice

21 January 2018

1 reference

Non-competitive NMDA receptor antagonists moderate seizure-induced c-fos expression in the rat cerebral cortex.

21 January 2018

1 reference

Differential antagonism of tetramethylenedisulfotetramine-induced seizures by agents acting at NMDA and GABA(A) receptors

21 January 2018

1 reference

Pathophysiological mechanisms of brain damage from status epilepticus

21 January 2018

1 reference

N-methyl-D-aspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy

21 January 2018

1 reference

Anticonvulsant, antiepileptogenic, and antiictogenic pharmacostrategies

21 January 2018

1 reference

Intrahippocampal cholinesterase inhibition induces epileptogenesis in mice without evidence of neurodegenerative events.

21 January 2018

1 reference

Ketamine and peripheral inflammation.

21 January 2018

1 reference

Anticonvulsants for nerve agent-induced seizures: The influence of the therapeutic dose of atropine

21 January 2018

1 reference

On the interactions between antimuscarinic atropine and NMDA receptor antagonists in anticholinesterase-treated mice.

21 January 2018

1 reference

Dizocilpine improves beneficial effects of cholinergic antagonists in anticholinesterase-treated mice

21 January 2018

1 reference

NMDA antagonists exert distinct effects in experimental organophosphate or carbamate poisoning in mice

21 January 2018

1 reference

Rational polytherapy in the treatment of acute seizures and status epilepticus

21 January 2018

1 reference

Effects of oral clonidine premedication on side effects of intravenous ketamine anesthesia: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat

21 January 2018

1 reference

Mechanism of action of memantine

21 January 2018

1 reference

The effect of co-administration of the NMDA blocker with agonist and antagonist of CB1-receptor on penicillin-induced epileptiform activity in rats.

21 January 2018

1 reference

Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat.

21 January 2018

1 reference

Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats

21 January 2018

1 reference

Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models

21 January 2018

1 reference

Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466

21 January 2018

1 reference

21 January 2018

1 reference

Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.

21 January 2018

1 reference

The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology

21 January 2018

1 reference

Two-methyl-6-phenylethynyl-pyridine (MPEP), a metabotropic glutamate receptor 5 antagonist, with low doses of MK801 and diazepam: a novel approach for controlling status epilepticus

21 January 2018

1 reference

Flunarizine: a possible adjuvant medication against soman poisoning?

21 January 2018

1 reference

Anticonvulsant and neuroprotective effects of the novel calcium antagonist NP04634 on kainic acid-induced seizures in rats.

21 January 2018

1 reference

Development of a prolonged calcium plateau in hippocampal neurons in rats surviving status epilepticus induced by the organophosphate diisopropylfluorophosphate

21 January 2018

1 reference

Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis.

21 January 2018

1 reference

Prolonged infusion of inhibitors of calcineurin or L-type calcium channels does not block mossy fiber sprouting in a model of temporal lobe epilepsy

21 January 2018

1 reference

Verapamil attenuates the malignant treatment course in recurrent status epilepticus

21 January 2018

1 reference

Blockade of the sodium calcium exchanger exhibits anticonvulsant activity in a pilocarpine model of acute seizures in rats

21 January 2018

1 reference

Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning

21 January 2018

1 reference

Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats

21 January 2018

1 reference

Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model

21 January 2018

1 reference

Revising a dogma: ketamine for patients with neurological injury?

21 January 2018

1 reference

Ketamine for rapid sequence induction in patients with head injury in the emergency department

21 January 2018

1 reference

The emerging use of ketamine for anesthesia and sedation in traumatic brain injuries

21 January 2018

1 reference

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

21 January 2018

1 reference

Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex

21 January 2018

1 reference

Preclinical assessment of ketamine

21 January 2018

1 reference

Ketamine potentiates cerebrocortical damage induced by the common anaesthetic agent nitrous oxide in adult rats

21 January 2018

1 reference

A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide

21 January 2018

1 reference

Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits

21 January 2018

1 reference

Ketamine anesthesia in brain-damaged epileptics: Electroencephalographic and clinical observations

21 January 2018

1 reference

Ketamine Hydrochloride and its Effect on a Chronic Cobalt Epileptic Cortical Focus

21 January 2018

1 reference

Ketamine and e.e.g. seizure waves: interaction with anti-epileptic drugs.

21 January 2018

1 reference

Ketamine activation of experimental corticoreticular epilepsy.

21 January 2018

1 reference

Effects of ketamine in epilepsy

21 January 2018

1 reference

The howling cortex: seizures and general anesthetic drugs

21 January 2018

1 reference

EFNS guideline on the management of status epilepticus.

21 January 2018

1 reference

Refractory status epilepticus: response to ketamine.

21 January 2018

1 reference

Terminating prolonged refractory status epilepticus using ketamine

21 January 2018

1 reference

Ketamine successfully terminates malignant status epilepticus

21 January 2018

1 reference

Efficacy and safety of ketamine in refractory status epilepticus in children

21 January 2018

1 reference

Early ketamine to treat refractory status epilepticus

21 January 2018

1 reference

Oral ketamine in paediatric non-convulsive status epilepticus

21 January 2018

1 reference

Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient

21 January 2018

1 reference

Ketamine as a neuroprotective and anti-inflammatory agent in children undergoing surgery on cardiopulmonary bypass: a pilot randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

Ketamine: a controversial drug for neonates

21 January 2018

1 reference

Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity

21 January 2018

1 reference

Anesthestic agents and status epilepticus

21 January 2018

1 reference

Complications of the management of status epilepticus in the intensive care unit

21 January 2018

1 reference

Total intravenous anesthesia including ketamine versus volatile gas anesthesia for combat-related operative traumatic brain injury

21 January 2018

1 reference

Perspectives: acute phencyclidine intoxication

21 January 2018

1 reference

Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor

21 January 2018

2 references

21 January 2018

12 December 2020

Anticonvulsants for soman-induced seizure activity

1 reference

12 December 2020

The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning.

1 reference

12 December 2020

Neuronal loss and synaptic reorganization in temporal lobe epilepsy

1 reference

12 December 2020

Role of ketamine in convulsions.

1 reference

12 December 2020

Evidence for GABA(A) receptor agonistic properties of ketamine: convulsive and anesthetic behavioral models in mice.

1 reference

12 December 2020

Effects of atropine sulphate on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neuropathology.

1 reference

12 December 2020

Normalization of spatial learning despite brain damage in rats receiving ketamine after seizure-induction: evidence for the neuromatrix

1 reference

12 December 2020

Acquisition and retrieval of conditioned taste aversion is impaired by brain damage caused by two hours of pilocarpine-induced status epilepticus.

1 reference

12 December 2020

Possible mechanism of anticonvulsant effect of ketamine in mice

1 reference

12 December 2020

Lack of interaction between the behavioral effects of ketamine and benzodiazepines in mice

1 reference

12 December 2020

Recent developments in treatment of status epilepticus: a review.

1 reference

12 December 2020

The brain matrix and multifocal brain damage following a single injection of ketamine in young adult rats: conspicuous changes in old age.

1 reference

12 December 2020

Ketamine: its use in the emergency department.

1 reference

12 December 2020

Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro

1 reference

12 December 2020

Standards of care for adults with convulsive status epilepticus: Belgian consensus recommendations.

1 reference

12 December 2020

1 reference

12 December 2020

Perioperative ketamine for acute postoperative pain

1 reference

12 December 2020

Ketamine: drug facts, uses in anesthesia, and new applications for analgesia

1 reference

12 December 2020

Standards of care for non-convulsive status epilepticus: Belgian consensus recommendations.

1 reference

12 December 2020

1 reference

12 December 2020

Status epilepticus treatment guidelines

1 reference

12 December 2020

Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice

1 reference

12 December 2020

Prise en charge en situation d’urgence et en réanimation des états de mal épileptiques de l’adulte et de l’enfant (nouveau-né exclu). Recommandations formalisées d’experts sous l’égide de la Société de réanimation de langue frança

1 reference

12 December 2020

Taming the ketamine tiger. 1965.

1 reference

12 December 2020

1 reference

12 December 2020

Refractory status epilepticus

1 reference

12 December 2020

Newer antiepileptic drugs in the treatment of status epilepticus: impact on prognosis

1 reference

12 December 2020

Status epilepticus and the use of continuous EEG monitoring in the intensive care unit.

1 reference

12 December 2020

1 reference

12 December 2020

Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives

1 reference

12 December 2020

MK-801 protects against seizures induced by the cholinesterase inhibitor soman

1 reference

12 December 2020

Ketamine and epilepsy.

1 reference

12 December 2020

Use of ketamine hydrochloride in the treatment of convulsions.

1 reference

12 December 2020

Ketamine-induced convulsions.

1 reference

12 December 2020

Ketamine-induced Electroconvulsive Phenomena in the Human Limbic and Thalamic Regions

1 reference

12 December 2020

Ketamine and epilepsy. Case report

1 reference

12 December 2020

Epilepsy or anesthesia with ketamine.

1 reference

12 December 2020

The EEG, evoked potentials, and single-unit activity during ketamine anesthesia in cats.

1 reference

12 December 2020

Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound

1 reference

12 December 2020

A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs

1 reference

12 December 2020

Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning

1 reference

12 December 2020

Ketamine's psychological effects do not contraindicate its use based on a patient's occupation

1 reference

12 December 2020

Antiepileptic effects of NBQX against soman-induced seizures

1 reference

12 December 2020

Coadministration of atropine, NBQX and TCP against soman-induced seizures

1 reference

12 December 2020

Convulsions following ketamine and atropine.

1 reference

12 December 2020

Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage

1 reference

12 December 2020

Integrated evaluation of central nervous system lesions: stains for neurons, astrocytes, and microglia reveal the spatial and temporal features of MK-801-induced neuronal necrosis in the rat cerebral cortex

1 reference

12 December 2020

Epileptiform activity and hippocampal damage produced by intrahippocampal injection of guanidinosuccinic acid in rat

1 reference

12 December 2020

In vivo protection against NMDA-induced neurodegeneration by MK-801 and nimodipine: combined therapy and temporal course of protection

1 reference

12 December 2020

[Ketamine and neuroprotection. Clinical outlook]

1 reference

12 December 2020

Electrographic tachyphylaxis to etomidate and ketamine used for refractory status epilepticus controlled with isoflurane.

1 reference

12 December 2020

GK 11: promising additional neuroprotective therapy for organophosphate poisoning

1 reference

12 December 2020

[Ketamine from an anticonvulsant perspective]

1 reference

12 December 2020

Ketamine: teaching an old drug new tricks

1 reference

12 December 2020

Ketamine--use in severe febrile convulsions

1 reference

12 December 2020

Identifiers

DOI

10.1111/CNS.12096

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6493567&resulttype=core&format=json

14 May 2020

23601960

1 reference